ApoC-III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists

FEBS Letters

Volumn 583, Issue 2, 2009, Pages 493-497

  Takahashi, Yu ^a   Inoue, Jun ^a   Kagechika, Hiroyuki ^b   Sato, Ryuichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adipocyte differentiation; apoC III; RXR

Indexed keywords

APOLIPOPROTEIN C3; CELL NUCLEUS RECEPTOR; HETERODIMER; MESSENGER RNA; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; APOLIPOPROTEIN C-III; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; MICE; RETINOID X RECEPTOR ALPHA;

EID: 58149516710     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.12.050     Document Type: Article

References (19)

1. Sarwar N., Danesh J., Eiriksdottir G., Sigurdsson G., Wareham N., Bingham S., Boekholdt S.M., Khaw K.T., and Gudnason V. Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies. Circulation 115 (2007) 450-458
2. Zannis V.I., Cole F.S., Jackson C.L., Kurnit D.M., and Karathanasis S.K. Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry 24 (1985) 4450-4455
3. Shachter N.S. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 12 (2001) 297-304
4. Carlson L.A., and Ballantyne D. Changing relative proportions of apolipoprotein C-II and C-III of very low density lipoproteins in hypertriglyceridemia. Atherosclerosis 23 (1976) 563-568
5. Ebara T., Ramakrishnan R., Steiner G., and Shachter N.S. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. J. Clin. Invest. 99 (1997) 2672-2681
6. Ito Y., Azrolan N., O'Connell A., Walsh A., and Breslow J.L. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249 (1990) 790-793
7. Maeda N., Li H., Lee D., Oliver P., Quarfordt S.H., and Osada J. Target disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269 (1994) 23610-23616
8. Duivenvoorden H., Teusink B., Rensen P.C., Romijn J.A., Havekes L.M., and Voshol P.J. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice. Diabetes 54 (2005) 664-671
9. Altomente J., Cong L., Harbaran S., Richter A., Xu J., Meseck M., and Dong H.H. Foxo1 mediated insulin action on apoC-III and triglyceride metabolism. J. Clin. Invest. 114 (2004) 1493-1503
10. Claudel T., Inoue Y., Barbier O., Duran-Sandoval D., Kosykh V., Fruchart J., Fruchart J.C., Gonzalez F.J., and Staels B. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 125 (2003) 544-555
11. Vu-Dac N., Gervois P., Torra I.P., Fruchart J.C., Kosykh V., Kooistra T., Princen H.M., Dallongeville J., and Staels B. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids. J. Clin. Invest. 102 (1998) 625-632
12. Schoonjans K., Peinado-Onsurbe J., Fruchart J.C., Tailleux A., Fiévet C., and Auwerx J. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase. FEBS Lett. 452 (1999) 160-164
13. Hertz R., Bishara-Shieban J., and Bar-Tana J. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270 (1995) 13470-13475
14. Takahashi B., Ohta K., Kawachi E., Fukasawa H., Hashimoto Y., and Kagechika H. Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions. J. Med. Chem. 45 (2002) 3327-3330
15. Kim K.A., Kim J.H., Wang Y., and Sul H.S. Pref-1 (preadipocyte factor-1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol. Cell Biol. 27 (2007) 2294-2308
16. Takahashi Y., Ohoka N., Hayashi H., and Sato R. TRB3 suppresses adipocyte differentiation by negatively regulating PPARγ transcriptional activity. J. Lipid Res. 49 (2008) 880-892
17. Kanayama T., Arito M., So K., Hachimura S., Inoue J., and Sato R. Interaction between sterol regulatory element-binding proteins and liver receptor homolog-1 reciprocally suppresses their transcriptional activities. J. Biol. Chem. 282 (2007) 10290-10298
18. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., and Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 (2003) 1655-1663
19. Zhang X.K., Lehmann J., Hoffmann B., Dawson M.I., Cameron J., Graupner G., Hermann T., Tran P., and Pfahl M. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358 (1992) 587-591